US EditionFury over decision to axe ‘last hope’ cancer treatment from NHS
Charities argue Tecartus offers a last hope for 600 UK patients yearly despite NICE citing lower survival rates of 2.5 years in real-world NHS data.
4 Articles
4 Articles
Charities launch appeal to reverse Nice decision on life-saving cancer treatment
Blood Cancer UK, Lymphoma Action and stem cell charity Anthony Nolan have formally appealed against the decision. A formal appeal has been sent to the NHS spending watchdog regarding its decision to remove a potentially life-saving cancer treatment from the health service in England and Wales. Tecartus – which engineers a patient’s own immune cells to kill cancer – was made available for people with a rare type of non-Hodgkin lymphoma through th…
The Independent
The Independent (US)Fury over decision to axe ‘last hope’ cancer treatment from NHS
It’s being called a ‘backward step for NHS care’
Charities appeal against NICE decision to remove the only CAR T-cell therapy for mantle cell lymphoma | The latest National and International News
Paul Madley, 66, had the Tecartus treatment (Paul Madley/PA) Paul Madley/PA Three leading blood cancer charities have launched a formal appeal to reverse a decision that strips a potentially life-saving treatment from NHS patients in England and Wales. Blood Cancer UK, Lymphoma Action, and Anthony Nolan are challenging the National Institute for Health and Care Excellence's ruling to remove Tecartus, the only CAR T-cell therapy available for man…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
